ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 953,25
0,23%
Dow Jones
38 441,54
0,00%
DAX
18 483,35
0,05%
Brent Oil
83,045
-0,40%
Bitcoin
67 829,82
0,36%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. Cotec Holdings Corp (CTH)

  7. Cotec Holdings Corp (CTH) Actualités

CTH

Cotec (CTH)

Cotec Holdings Corp
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:CTH
DateHeureSourceTitreSymboleSociété
19/11/201415h35PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - CTHTSXV:CTHCotec Holdings Corp
19/11/201415h33PR Newswire (Canada)IIROC Trading Resumption - CTHTSXV:CTHCotec Holdings Corp
18/11/201422h12PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - CTHTSXV:CTHCotec Holdings Corp
18/11/201422h10PR Newswire (Canada)IIROC Trading Halt - CTHTSXV:CTHCotec Holdings Corp
17/07/201422h15Marketwired CanadaCynapsus Therapeutics Commences Phase 2 Clinical Trials in the United StatesTSXV:CTHCotec Holdings Corp
08/07/201412h00Marketwired CanadaCynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's ResearchTSXV:CTHCotec Holdings Corp
20/05/201422h42MarketwiredCynapsus Therapeutics Grants Stock OptionsTSXV:CTHCotec Holdings Corp
14/05/201412h00MarketwiredCynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
07/05/201423h30Marketwired CanadaCynapsus Therapeutics Reports First Quarter 2014 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
24/04/201412h00MarketwiredCynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
15/04/201416h27Marketwired CanadaCynapsus Therapeutics Completes $25,000,000 Short Form Prospectus OfferingTSXV:CTHCotec Holdings Corp
09/04/201404h14Marketwired CanadaCynapsus Therapeutics Files Final Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201421h50Marketwired CanadaCynapsus Therapeutics Files Preliminary Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201411h00MarketwiredCynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-130277TSXV:CTHCotec Holdings Corp
27/03/201421h00MarketwiredCynapsus Therapeutics Reports 2013 Financial Results and Highlights Key DevelopmentsTSXV:CTHCotec Holdings Corp
27/02/201415h22MarketwiredCynapsus Therapeutics Announces DTC ApprovalTSXV:CTHCotec Holdings Corp
13/02/201414h00MarketwiredCynapsus Therapeutics Appoints Nan Hutchinson to the Board of DirectorsTSXV:CTHCotec Holdings Corp
07/02/201415h15MarketwiredLifeSci Advisors Initiates Coverage of Cynapsus Therapeutics, Inc.TSXV:CTHCotec Holdings Corp
23/01/201422h00MarketwiredCynapsus Therapeutics Announces Exercise of WarrantsTSXV:CTHCotec Holdings Corp
22/01/201422h30MarketwiredCynapsus Announces Resignation of Chief Scientific OfficerTSXV:CTHCotec Holdings Corp
13/01/201412h00MarketwiredCynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-130277TSXV:CTHCotec Holdings Corp
26/11/201314h00Marketwired CanadaSeeThruEquity, LLC Initiates Coverage on Cynapsus Therapeutics Inc.TSXV:CTHCotec Holdings Corp
21/11/201321h42Marketwired CanadaCynapsus Therapeutics Reports Third Quarter 2013 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
10/10/201317h04Marketwired CanadaGoldquest, Micromem Technologies, Cynapsus Therapeutics and Excalibur Resources Featured on Episode 14 of the Next Biggest Wi...TSXV:CTHCotec Holdings Corp
22/08/201322h17Marketwired CanadaCynapsus Therapeutics Reports Second Quarter 2013 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
18/07/201313h00Marketwired CanadaCynapsus Therapeutics Begins Trading on the OTCQX Marketplace in the United StatesTSXV:CTHCotec Holdings Corp
30/05/201315h00Marketwired CanadaCynapsus Therapeutics to Present at the SeeThruEquity Second Annual Investor Conference on June 4, 2013 at 10:00 AM EDTTSXV:CTHCotec Holdings Corp
23/05/201315h28Marketwired CanadaCynapsus Therapeutics Reports First Quarter 2013 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
15/05/201312h00Marketwired CanadaCynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Disease and Its Alternative Deliv...TSXV:CTHCotec Holdings Corp
09/05/201322h45Marketwired CanadaCynapsus Therapeutics Appoints Two New DirectorsTSXV:CTHCotec Holdings Corp
 Showing the most relevant articles for your search:TSXV:CTH

Dernières Valeurs Consultées

LSE
95NM
Ing Bank 10yr29
OKEX
BBCBTC
LSE
53LM
Investec Bnk 24
LSE
79NK
Investec Bnk 23
TG
AMD
Advanced Micro Devices
BIT
UI598C
Unicredit Bank
NASDAQ
CHRDD
COIN
OHMIETH
One Hundred Million Inu
COIN
FOURRETH
Four
LSE
BB45
Santa Fe Stlg
LSE
77HV
Investec Bnk 23
UNSW3
AVINOCUSDT
AVINOC Token
TG
WA3
Casella Waste Sys A Dl 01
LSE
93GC
Inter-amer 39
LSE
73MF
Investec Bnk 23
LSE
47IZ
Inter-amer Nts
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés